Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:GEV
NYSE:GEVElectrical

GE Vernova (GEV) Earnings Surge And 12.8% Margin Test Rich Valuation Narratives

GE Vernova (GEV) closed out FY 2025 with Q4 revenue of US$10.96b and basic EPS of US$13.57, alongside net income excluding extra items of US$3,664m, capping a year in which trailing twelve month EPS reached US$17.96 on revenue of US$38.07b. Over the past six quarters, the company has seen quarterly revenue move from US$8,913m in Q3 2024 to US$10,558m in Q4 2024 and then to US$10,956m in Q4 2025, while basic EPS shifted from a loss of US$0.35 in Q3 2024 to US$1.75 in Q4 2024 and then to...
LSE:GLEN
LSE:GLENMetals and Mining

Reassessing Glencore (LSE:GLEN) After A 48% One Year Share Price Surge

If you are wondering whether Glencore's current share price reflects its true value, you are not alone. This article will walk through what the latest valuation checks are actually saying. Glencore's stock has posted returns of 3.6% over the last 7 days, 24.9% over the last 30 days, 24.2% year to date and 48.0% over the last year, with a 3 year return of 7.7% and a 5 year return of 162.7%. Recent coverage around Glencore has focused on the stock's strong multi year performance and its...
NasdaqGS:PTCT
NasdaqGS:PTCTBiotechs

Converging Analyst Upgrades on PTC’s Rare Disease Pipeline Might Change The Case For Investing In PTC Therapeutics (PTCT)

In recent days, Barclays upgraded PTC Therapeutics to an Overweight rating, while other brokers continued to rate the biotech as Outperform, underscoring growing analyst optimism around the company’s rare disease portfolio. This convergence of positive views, anchored in PTC’s therapies for conditions such as Duchenne muscular dystrophy and AADC deficiency, highlights how analyst sentiment can crystallize around a focused clinical pipeline. Next, we’ll examine how this strengthened analyst...
NYSE:MPT
NYSE:MPTHealth Care REITs

Medical Properties Trust Headquarters Move Adds Context To Cost And Execution Story

Medical Properties Trust (NYSE:MPW) has relocated its corporate headquarters to a new address in Alabama. The move marks an official change in the company’s primary base of operations. Medical Properties Trust focuses on investing in hospital and healthcare facilities, with tenants that operate across a range of medical services. A headquarters relocation can affect how leadership is organized, how teams work together and how resources are allocated across the portfolio. For you as an...
NasdaqCM:POET
NasdaqCM:POETSemiconductor

Assessing POET Technologies (NasdaqCM:POET) Valuation After Its Recent Follow On Offering And Shelf Registration

POET Technologies (NasdaqCM:POET) has drawn fresh attention after completing a US$150.000006 million registered direct follow on equity offering at US$7.25 per share, issuing 20,689,656 new common shares to investors. See our latest analysis for POET Technologies. The follow on offering and shelf registration have arrived during a weaker patch for the stock, with a 7 day share price return of 14.27% decline and a year to date share price return of 16.90% decline. However, the 1 year total...
KOSDAQ:A108490
KOSDAQ:A108490Electronic

High Growth Tech Stocks in Asia with Promising Potential

Amidst a backdrop of global market volatility and geopolitical uncertainties, the Asian tech sector continues to capture investor interest with its dynamic growth potential. As we explore three high-growth tech stocks in Asia, it's essential to consider factors such as innovation, scalability, and adaptability to shifting economic conditions that can drive long-term success in this rapidly evolving landscape.
SGX:T6I
SGX:T6IConsumer Finance

Uncovering Asia's Undiscovered Gems This January 2026

As we enter January 2026, Asian markets are navigating a landscape marked by mixed economic indicators and geopolitical uncertainties, with key indices reflecting both challenges and opportunities. In this dynamic environment, identifying promising small-cap stocks requires a keen understanding of market conditions and the ability to spot companies that demonstrate resilience and growth potential amidst broader volatility.
ENXTAM:APAM
ENXTAM:APAMMetals and Mining

Does Aperam’s New “Slink” Motor-Alloy Breakthrough Reshape The Bull Case For Aperam (ENXTAM:APAM)?

In January 2026, Aperam announced its new "slink" production method, adapting in-plane helical bending to iron-cobalt alloys to manufacture stators and rotors more efficiently and with sharply reduced material waste for high-performance electric motors. By pairing the "slink" process with its AFK iron-cobalt alloys, Aperam is opening new design options for electric propulsion in aviation, eVTOL aircraft, and hypercars while supporting more sustainable use of high-cost materials. We’ll now...
NYSE:LHX
NYSE:LHXAerospace & Defense

L3Harris Technologies (LHX) Net Margin Steady At 7.3% Reinforces Measured Bullish Narratives

L3Harris Technologies (LHX) closed out FY 2025 with fourth quarter revenue of US$5.6b and basic EPS of US$1.60, alongside net income of US$300m, while trailing twelve month EPS stood at US$8.57 on revenue of US$21.9b and net income of US$1.6b. Over the past six quarters, the company has seen quarterly revenue move from US$5.3b in Q3 2024 to US$5.6b in Q4 2025, with basic EPS ranging between US$1.60 and US$2.47 and net income between US$300m and US$462m, setting a clear earnings profile for...